Okay, I understand, but your points tend to suggest a plan for a long term position, not a 'run up' and sell strategy.
If, as you put it, the RA Phase II data proves the tc99m backbone for other diagnostics, and for therapy, then that would open a floodgate of partners and be reason for a long term position, not a run up and sell strategy.
Like I have said many times before, if the tc99m was really proven for the indications given, big pharma would be all over this little company like stink on shit. Again, that's a strategy for a long term position, though.
I guess what I am saying is that if you are correct about the RA trail proving the theory behind tc99m, why would you want to sell?